| Literature DB >> 25909061 |
Abstract
BACKGROUND: The purpose of this study was to determine whether a 45 bp insertion/deletion (I/D) polymorphism in human uncoupling protein 2 (hUCP2) gene was associated with changes in several cardiovascular risk and physical fitness factors in response to combined exercise during 12 weeks in Korean middle-aged women. The changes in physiological parameters after combined exercise during 12 weeks were compared between each genotype subgroups of hUCP2 gene to clarify the inter-individual differences in exercised-induced changes according to genetic predisposition.Entities:
Keywords: Cardiovascular risk factors; Combined exercise; Korea; Polymorphism; hUCP2
Year: 2014 PMID: 25909061 PMCID: PMC4401058
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
Clinical characteristics of participants
| Variables | No. | Mean ± SD |
|---|---|---|
| Age (yr) | 185 | 48.4 ± 11.6 |
| Height (cm) | 185 | 156.4 ± 6.2 |
| Weight (kg) | 164 | 66.1 ± 11.5 |
| BMI (kg/m2) | 164 | 28.6 ± 22.8 |
| %Body fat (%) | 164 | 34.0 ± 5.6 |
| SBP (mmHg) | 153 | 127.5 ± 17.5 |
| DBP (mmHg) | 153 | 77.7 ± 12.1 |
| MAP (mmHg) | 153 | 61.1 ± 11.8 |
| Pulse pressure (mmHg) | 153 | 49.8 ± 10.4 |
| Mus. Strength (kg) | 108 | 28.7 ± 5.8 |
| Mus. end. (count/min) | 103 | 9.5 ± 8.8 |
| Power (cm) | 99 | 17.0 ± 7.5 |
| Flexibility (cm) | 152 | 12.1 ± 7.7 |
| Agility (msec) | 108 | 380.4 ± 123.1 |
| TC (mg/dL) | 183 | 208.5 ± 39.1 |
| TG (mg/dL) | 151 | 134.3 ± 81.5 |
| HDL-Chol. (mg/dL) | 157 | 56.5 ± 10.4 |
| LDL-Chol. (mg/dL) | 126 | 123.1 ± 35.2 |
| Glucose (mg/dL) | 153 | 97.5 ± 31.1 |
The changes in body composition and clinical parameters following 12 wk combined training
| Variables | Mean±SD(No.) | |||
|---|---|---|---|---|
| Pre | Post | |||
| Height (cm) | 156.4 ± 5.7(108) | 156.6 ± 5.6(108) | -3.955 | <0.001* |
| Weight (kg) | 65.2 ± 12.2(108) | 63.8 ± 11.4(108) | 4.263 | <0.001* |
| BMI (kg/m2) | 26.6 ± 4.6(108) | 26.0 ± 4.3(108) | 6.266 | <0.001* |
| %Body fat (%) | 33.1 ± 5.9(108) | 32.0 ± 6.4(108) | 5.542 | <0.001* |
| SBP (mmHg) | 128.7 ± 17.7(96) | 123.1 ± 16.2(96) | 4.207 | <0.001* |
| DBP(mmHg) | 78.5 ± 11.7(96) | 74.7 ± 10.4(96) | 3.533 | 0.001* |
| MAP(mmHg) | 61.8 ± 11.5(96) | 58.6 ± 10.0(96) | 2.742 | 0.007* |
| Pulse pressure (mmHg) | 50.1 ± 11.0(96) | 48.4 ± 9.9(96) | 1.832 | 0.070* |
| Mus. Strength (kg) | 28.5 ± 6.1(60) | 29.4 ± 5.0(60) | -1.587 | 0.118 |
| Mus. end. (count/min) | 9.1 ± 5.9(58) | 12.1 ± 5.5(58) | -6.153 | <0.001* |
| Power (cm) | 16.2 ± 6.4(53) | 18.6 ± 7.4(53) | -4.514 | <0.001* |
| Flexibility (cm) | 12.2 ± 8.0(97) | 18.8 ± 23.8(97) | -2.980 | 0.004* |
| Agility (msec) | 403.9 ± 128.2(61) | 339.9 ± 91.5(61) | 4.000 | <0.001* |
| TC (mg/dL) | 207.4 ± 42.8(109) | 202.5 ± 39.7(109) | 1.387 | 0.168 |
| TG (mg/dL) | 132.0 ± 68.7(95) | 113.9 ± 50.9(95) | 3.557 | 0.001* |
| HDL-Chol. (mg/dL) | 54.6 ± 10.1(83) | 53.2 ± 9.6(83) | 1.696 | 0.094 |
| LDL-Chol. (mg/dL) | 123.9 ± 37.9(70) | 126.1 ± 36.6(70) | -0.561 | 0.577 |
| Glucose (mg/dL) | 98.9 ± 26.5(96) | 99.0 ± 20.3(96) | -0.011 | 0.991 |
The genotype and allele frequencies of the I/D polymorphism in the UCP2 gene
| Genotype | No.(%) | Allele | No. (%) |
|---|---|---|---|
| II | 17(9.2) | I | 93(25.1) |
| ID | 59(31.9) | D | 277(74.9) |
| DD | 109(58.9) | ||
| Total | 185(100.0) | 370(100.0) |
Body composition parameters at baseline and in changes following a 12 wk combined training program according to the genotypes of the I/D polymorphism in the UCP2 gene
| Variable | Mean ± SD(No.) | |||
|---|---|---|---|---|
| II+ID | DD | |||
| Height (cm) | ||||
| Baseline | 155.6 ± 5.2(43) | 156.9 ± 6.0(65) | -1.202 0.232 | |
| Change | 0.2 ± 0.5(43) | 0.2 ± 0.6(65) | -0.174 0.863 | |
| Weight (kg) | ||||
| Baseline | 63.0 ± 10.2(43) | 66.7 ± 13.2(65) | -1.559 | 0.122 |
| Change | -1.2 ± 1.8(43) | -1.5 ± 4.0(65) | 0.393 | 0.695 |
| BMI (kg/m2) | ||||
| Baseline | 26.0 ± 4.0(43) | 26.9 ± 4.9(65) | -0.997 | 0.321 |
| Change | -0.6 ± 0.7(43) | -0.5 ± 1.1(65) | -0.343 | 0.732 |
| %Body fat (%) | ||||
| Baseline | 31.4 ± 6.2(43) | 34.2 ± 5.4(65) | -2.479 | 0.015(< 0.05.) |
| Change | -2.0 ± 2.4(43) | -0.6 ± 1.8(65) | -3.249 | 0.002*(< 0.05.) |
Hemodynamic parameters at baseline and in changes following a 12 wk combined training program according to the genotypes of the I/D polymorphism in the UCP2 gene
| Variable | Mean ± SD(No.) | t-value | ||
|---|---|---|---|---|
| II+ID | DD | |||
| SBP (mmHg) | ||||
| Baseline | 128.3 ± 17.0(40) | 128.9 ± 18.3(56) | -0.154 | 0.878 |
| Change | -6.1± 12.0(40) | -5.1 ±13.6(56) | -0.341 | 0.734 |
| DBP (mmHg) | ||||
| Baseline | 78.7± 11.7(40) | 78.4 ± 11.8(56) | 0.084 | 0.934 |
| Change | -2.6 ± 8.9(40) | -4.6 ± 11.5(56) | 0.914 | 0.363 |
| MAP (mmHg) | ||||
| Baseline | 62.1 ± 11.9(40) | 61.6 ± 11.3(56) | 0.193 | 0.847 |
| Change | -1.5 ± 9.8(40) | -4.4 ± 12.4(56) | 1.253 | 0.213 |
| Pulse pressure (mmHg) | ||||
| Baseline | 49.7 ± 11.1(40) | 50.4 ± 11.0(56) | -0.339 | 0.736 |
| Change | -3.5 ± 9.1(40) | -0.5 ± 9.5(56) | -1.501 | 0.137 |
Physical fitness factors at baseline and in changes following a 12 wk combined training program according to the genotypes of the I/D polymorphism in the UCP2 gene
| Variable | Mean ± SD(No.) | t-value | ||
|---|---|---|---|---|
| II+ID | DD | |||
| Mus. Strength (kg) | ||||
| Baseline | 27.7 ± 7.0(15) | 28.7 ± 5.8(45) | -0.561 | 0.577 |
| Change | 0.9 ± 6.3(15) | 0.9 ± 3.8(45) | 0.051 | 0.960 |
| Mus. end. (count/min) | ||||
| Baseline | 9.3 ± 6.2(16) | 9.0 ± 5.9(42) | 0.192 | 0.849 |
| Change | 3.3 ± 3.4(16) | 2.9 ± 3.9(42) | 0.291 | 0.772 |
| Power (cm) | ||||
| Baseline | 15.6 ± 6.0(14) | 16.5 ± 6.6(39) | -0.458 | 0.649 |
| Change | 3.2 ± 4.9(14) | 2.1 ± 3.4(39) | 0.806 | 0.431 |
| Flexibility (cm) | ||||
| Baseline | 11.1 ± 7.0(42) | 13.0 ± 8.6(55) | -1.180 | 0.241 |
| Change | 5.8 ± 4.3(42) | 7.2 ± 28.9(55) | -0.138 | 0.751 |
| Agility (msec) | ||||
| Baseline | 419.5 ± 142.5(17) | 397.8 ± 123.5(44) | 0.590 | 0.558 |
| Change | -101.4 ± 131.1(17) | -49.5 ± 120.8(44) | -1.467 | 0.148 |
Biochemical parameters at baseline and in changes following a 12 wk combined training program according to the genotypes of the I/D polymorphism in the UCP2 gene
| Variable | Mean ± SD(No.) | |||
|---|---|---|---|---|
| II+ID | DD | |||
| TC (mg/dl) | ||||
| Baseline | 207.1 ± 48.8(45) | 207.6 ± 38.5(64) | -0.055 | 0.956 |
| Change | -11.8 ± 39.5(45) | -0.3 ± 34.3(64) | -1.617 | 0.109 |
| TG (mg/dl) | ||||
| Baseline | 147.9 ± 79.7(40) | 120.5 ± 57.5(55) | -1.948 | 0.054 |
| Change | -33.7 ± 51.0(40) | 5.9 ± 45.9(55) | -3.965 | <0.001* |
| LDL-chol (mg/dl) | ||||
| Baseline | 120.0 ± 38.0(19) | 125.3 ± 38.1(51) | -0.524 | 0.602 |
| Change | 1.6 ± 28.6(19) | 2.5 ± 36.1(51) | -0.105 | 0.917 |
| HDL-chol (mg/dl) | ||||
| Baseline | 53.7 ± 8.0(23) | 54.9 ± 10.8(60) | -0.455 | 0.651 |
| Change | -0.6 ± 7.2(23) | -1.7 ± 7.5(60) | 0.582 | 0.562 |
| Glucose (mg/dl) | ||||
| Baseline | 104.9 ± 28.0(41) | 94.5 ± 24.7(55) | 1.880 | 0.064 |
| Change | 10.1 ± 19.2(41) | 3.9 ± 15.4(55) | 1.731 | 0.087 |